Arvind Arumainathan

513 total citations
5 papers, 21 citations indexed

About

Arvind Arumainathan is a scholar working on Pathology and Forensic Medicine, Genetics and Neurology. According to data from OpenAlex, Arvind Arumainathan has authored 5 papers receiving a total of 21 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 2 papers in Genetics and 2 papers in Neurology. Recurrent topics in Arvind Arumainathan's work include Lymphoma Diagnosis and Treatment (3 papers), Viral-associated cancers and disorders (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Arvind Arumainathan is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Viral-associated cancers and disorders (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Arvind Arumainathan collaborates with scholars based in United Kingdom, Germany and United States. Arvind Arumainathan's co-authors include Wendy Osborne, Paul Flanagan, Kim Linton, Karl S. Peggs, Fiona Miall, Sarah E. Coupland, David W. Eyre, Catherine Booth, Graham P. Collins and Elizabeth H. Phillips and has published in prestigious journals such as Blood, Gut and British Journal of Haematology.

In The Last Decade

Arvind Arumainathan

5 papers receiving 21 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arvind Arumainathan United Kingdom	3	16	10	7	6	5	5	21
Suzanne Allibone United States	2	14 0.9×	10 1.0×	7 1.0×	4 0.7×	3 0.6×	2	16
Mónica Baile Spain	2	13 0.8×	10 1.0×	12 1.7×	5 0.8×	5 1.0×	8	21
Giovanni Paolo Maria Zambrotta Italy	2	9 0.6×	9 0.9×	4 0.6×	3 0.5×	5 1.0×	4	15
Isabel Lentell United Kingdom	3	11 0.7×	7 0.7×	9 1.3×	2 0.3×	4 0.8×	3	21
Stéphane Doucet Canada	4	17 1.1×	10 1.0×	13 1.9×	14 2.3×	2 0.4×	12	34
John C. Chan United States	2	20 1.3×	11 1.1×	4 0.6×	12 2.0×	1 0.2×	2	20
Sophy Denker Germany	4	23 1.4×	20 2.0×	3 0.4×	10 1.7×	4 0.8×	5	35
William Honeycutt United States	3	14 0.9×	5 0.5×	3 0.4×	2 0.3×	6 1.2×	4	17
Giulia Palazzo Italy	5	12 0.8×	16 1.6×	5 0.7×	11 1.8×	13 2.6×	6	36
Theresa Davey United States	4	28 1.8×	15 1.5×	3 0.4×	3 0.5×	19 3.8×	4	33

Countries citing papers authored by Arvind Arumainathan

Since Specialization

Citations

This map shows the geographic impact of Arvind Arumainathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Arumainathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Arumainathan more than expected).

Fields of papers citing papers by Arvind Arumainathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvind Arumainathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Arumainathan. The network helps show where Arvind Arumainathan may publish in the future.

Co-authorship network of co-authors of Arvind Arumainathan

This figure shows the co-authorship network connecting the top 25 collaborators of Arvind Arumainathan. A scholar is included among the top collaborators of Arvind Arumainathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvind Arumainathan. Arvind Arumainathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Roeker, Lindsey E., Jennifer R. Brown, Peter Dreger, et al.. (2019). Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents. Blood. 134(Supplement_1). 3321–3321. 1 indexed citations

2.

Khan, Umair, et al.. (2018). Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis. British Journal of Haematology. 183(3). 345–345. 1 indexed citations

3.

Eyre, Toby A., Elizabeth H. Phillips, Kim Linton, et al.. (2017). Results of a multicentre UK‐wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting. British Journal of Haematology. 179(3). 471–479. 15 indexed citations

4.

Flanagan, Paul, Sarah E. Coupland, Arvind Arumainathan, & Chris Probert. (2013). A rare cause of weight loss. Gut. 63(6). 1024–1024. 2 indexed citations

5.

Arumainathan, Arvind, Nagesh Kalakonda, & Andrew R. Pettitt. (2011). Lenalidomide can be highly effective in chronic lymphocytic leukaemia despite T‐cell depletion and deletion of chromosome 17p. European Journal Of Haematology. 87(4). 372–375. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact